Skip to search formSkip to main contentSkip to account menu

ICI 185282

Known as: ICI 185,282, ICI-185282 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dioxanes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Disturbance of Macrophage and Monocyte Function in the Dog by a Thromboxane Receptor Antagonist: ICI 185,282
ICI 185,282 is a specific thromboxane receptor antagonist developed by ZENECA Pharmaceuticals for potential use in the treatment… 
1991
1991
Synergism between UK 38485 and ICI 185282 against digoxin-induced arrhythmias in guinea-pigs.
In this study, the combination of a thromboxane synthetase inhibitor (UK 38485) and a thromboxane receptor antagonist (ICI 185282… 
1988
1988
Studies In The Guinea‐pig With ICI 185,282: A Thromboxane A2 Receptor Antagonist
Abstract— The effects of ICI 185,282 (5(Z)‐7‐([2,4,5‐cis]‐4‐O‐hydroxyphenyl‐2‐trifluoromethyl‐1,3‐dioxan‐5‐yl)heptenoic acid… 
1988
1988
EFFECTS OF THROMBOXANE SYNTHETASE INHIBITOR (UK 38,485) AND THROMBOXANE RECEPTOR ANTAGONIST (ICI 185,282) ON DIGOXIN‐INDUCED ARRHYTHMIAS IN ANAESTHETIZED GUINEA‐PIGS
1. Increased local thromboxane (Tx) formation has been considered to be a contributing factor in digitalis‐induced arrhythmias. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)